Search Results 261-270 of 17147 for nivolumab
IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases. Rochester, Minn. The purpose of this study is to evaluate the reduction in the ...
... Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301). Jacksonville, Fla. The purpose of this study is for IMC-F106C plus nivolumab ...
The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...
Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...
... Nivolumab or Nivolumab/Relatlimab). Exclusion Criteria: Concurrent chemotherapy. Eligibility last updated 11/2/22. Questions regarding updates should be ...
Nivolumab shows significant benefit for Hodgkin's lymphoma in Mayo Clinic co-led phase I study. Joe Dangor. December 5, 2014. Mayo Clinic's Discovery's Edge ...
The purpose of this study is to evaluate CMN-001 in a randomized trial between standard-of-care (SOC) (first line ipilimumab+nivolumab followed by second ...
... Nivolumab) in < 14 days. The secondary objective of this study is to assess the association between standard of care drug sensitivity in MOS to clinical ...
... (nivolumab) treatment plus platinum doublet chemotherapy. . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!